Literature DB >> 21556773

A meta-analysis of HLA-DR polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy.

Bo Jin1, Xin-Ping Luo, Huan-Chun Ni, Wei Shen, Hai-Ming Shi, Yong Li.   

Abstract

Idiopathic dilated cardiomyopathy (IDC) has been hypothesized as a multifactorial disorder initiated by an environment trigger in individuals with predisposing human leukocyte antigen (HLA) alleles. Published data on the association between HLA-DR polymorphism and IDC risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. A total of 19 case-control studies including 1,378 cases and 10,383 controls provided data on the association between HLA-DR polymorphism and genetic susceptibility to IDC. Overall, statistically elevated frequencies of HLA-DR4 (OR 1.58; 95% CI 1.21-2.07; P=0.0009) and HLA-DR5 (OR 1.35; 95% CI 1.05-1.73; P=0.02) alleles were found in patients with IDC compared with controls. Individuals with HLA-DR3 antigen have a protective effect against IDC (OR 0.72; 95% CI 0.58-0.90; P=0.004). In summary, this meta-analysis indicated that certain HLA-DR alleles may be genetic markers for susceptibility and resistance to IDC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21556773     DOI: 10.1007/s11033-011-0729-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  28 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Idiopathic dilated cardiomyopathy. An immunologic, genetic, or infectious disease, or all of the above?

Authors:  J R Bender
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

3.  Association of HLA class II DRB1, DPA1 and DPB1 polymorphism with genetic susceptibility to idiopathic dilated cardiomyopathy in Chinese Han nationality.

Authors:  Wei Liu; Wei-Min Li; Shu-Sen Yang; Cheng Gao; Shao-Jun Li; Yue Li; Yi-Hui Kong; Run-Tao Gan
Journal:  Autoimmunity       Date:  2006-09       Impact factor: 2.815

Review 4.  Idiopathic dilated cardiomyopathy.

Authors:  G W Dec; V Fuster
Journal:  N Engl J Med       Date:  1994-12-08       Impact factor: 91.245

Review 5.  Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.

Authors:  Alida L P Caforio; Niall J Mahon; Francesco Tona; William J McKenna
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

6.  Do specific HLA antigens predispose to ischaemic heart disease or idiopathic dilated cardiomyopathy?

Authors:  S C Grant; S Sheldon; P A Dyer; R D Levy; N H Brooks
Journal:  Br Heart J       Date:  1994-01

7.  Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy.

Authors:  J F Carlquist; R H Ward; D Husebye; M Feolo; J L Anderson
Journal:  Am J Cardiol       Date:  1994-11-01       Impact factor: 2.778

8.  HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors.

Authors:  J L Anderson; J F Carlquist; J R Lutz; C W DeWitt; E H Hammond
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

9.  DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy.

Authors:  H Nishi; Y Koga; T Koyanagi; H Harada; T Imaizumi; H Toshima; T Sasazuki; A Kimura
Journal:  J Mol Cell Cardiol       Date:  1995-10       Impact factor: 5.000

10.  Idiopathic dilated cardiomyopathy: lack of association between circulating organ-specific cardiac antibodies and HLA-DR antigens.

Authors:  A L Caforio; M Martinetti; G Schwarz; E Bonifacio; A Gavazzi; G Graziano; R Lorini; M Cuccia; W J McKenna; G F Bottazzo
Journal:  Tissue Antigens       Date:  1992-05
View more
  3 in total

1.  The frequency of diastolic dysfunction in patients with sarcoidosis and it's relationship with HLA DRB1* alleles.

Authors:  Ezgi Ozyilmaz; Rabia Akilli; İlayda Berk; Ali Deniz; Ozlem Goruroglu Ozturk; Oya Baydar; Yasemin Saygideger; Gulsah Seydaoglu; Eren Erken
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

2.  Prioritizing disease candidate proteins in cardiomyopathy-specific protein-protein interaction networks based on "guilt by association" analysis.

Authors:  Wan Li; Lina Chen; Weiming He; Weiguo Li; Xiaoli Qu; Binhua Liang; Qianping Gao; Chenchen Feng; Xu Jia; Yana Lv; Siya Zhang; Xia Li
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

3.  A humanized HLA-DR4 mouse model for autoimmune myocarditis.

Authors:  M Emrah Şelli; Anita C Thomas; David C Wraith; Andrew C Newby
Journal:  J Mol Cell Cardiol       Date:  2017-04-18       Impact factor: 5.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.